Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at :

NCT ID NCT04391049
Title Testing the Addition of the Anti-cancer Viral Therapy Telomelysin to Chemoradiation for Patients With Advanced Esophageal Cancer and Are Not Candidates for Surgery
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors NRG Oncology
Age Groups: senior | adult
Covered Countries USA

No variant requirements are available.